Earningsreport

Q1/2019 3/31/2019 EPS -0.540 ZacksConsensus N/A ActVsEst N/A - N/A

ReShape Lifesciences, Inc.  (RSLS) 
US:NASDAQ Investor Relations: ir.enteromedics.com